1. Home
  2. CCEL vs CNVS Comparison

CCEL vs CNVS Comparison

Compare CCEL & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.62

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$2.39

Market Cap

65.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCEL
CNVS
Founded
1989
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
65.5M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
CCEL
CNVS
Price
$3.62
$2.39
Analyst Decision
Hold
Buy
Analyst Count
1
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
15.0K
123.6K
Earning Date
04-14-2026
02-17-2026
Dividend Yield
4.12%
N/A
EPS Growth
N/A
108.99
EPS
N/A
N/A
Revenue
$25,384,279.00
$78,181,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$84.42
P/E Ratio
N/A
N/A
Revenue Growth
9.76
59.13
52 Week Low
$2.72
$1.77
52 Week High
$6.37
$7.39

Technical Indicators

Market Signals
Indicator
CCEL
CNVS
Relative Strength Index (RSI) 68.24 45.00
Support Level $3.13 $2.34
Resistance Level $4.76 $2.47
Average True Range (ATR) 0.18 0.15
MACD 0.07 -0.02
Stochastic Oscillator 98.94 40.11

Price Performance

Historical Comparison
CCEL
CNVS

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

Share on Social Networks: